# China Home Infusion Therapy Devices Market

> China Home Infusion Therapy Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Infusion Pumps, Syringe Pumps, Ambulatory Pumps, Enteral Feeding Pumps), By Therapy Type (Antibiotic Therapy, Chemotherapy, Nutrition Therapy, Pain Management), By End Users (Hospitals, Home Care Settings, Nursing Homes) and By Components (Infusion Set, Catheters, Accessories, Software Solutions) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.09%
- **2024:** $ 512.25 Million
- **2025:** $ 538.32 Million
- **2035:** $ 884.4 Million
- **Key Players:** Baxter International Inc (US), B. Braun Melsungen AG (DE), Fresenius Kabi AG (DE), Medtronic plc (IE), Smiths Medical (US), ICU Medical Inc (US), Terumo Corporation (JP), Halyard Health Inc (US), Zyno Medical LLC (US)

**Report ID:** MRFR/Pharma/49007-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/china-home-infusion-therapy-devices-market-50764

---

## Market Summary

## **China Home Infusion Therapy Devices Market Overview**

As per MRFR analysis, the China Home Infusion Therapy Devices Market Size was estimated at 1.42 (USD Billion) in 2023. The China Home Infusion Therapy Devices Market Industry is expected to grow from 1.49 (USD Billion) in 2024 to 3.68 (USD Billion) by 2035. The China Home Infusion Therapy Devices Market CAGR (growth rate) is expected to be around 8.571% during the forecast period (2025 - 2035).

### **Key China Home Infusion Therapy Devices Market Trends Highlighted**

The China Home Infusion Therapy Devices Market is experiencing significant shifts driven by several key market drivers. Firstly, the rising aging population in China is creating a growing demand for home healthcare solutions, including infusion therapy devices. The government’s emphasis on enhancing healthcare infrastructure and increasing access to medical services in rural and urban areas is facilitating the availability and adoption of these devices. Furthermore, the shift in patient preferences towards home treatments, as patients seek comfort and convenience, is propelling market growth.

There are numerous opportunities to be explored within the market. Emerging technologies like Smart infusion systems and advanced monitoring capabilities offer new opportunities for innovation. Additionally, the growing burden of chronic diseases such as diabetes and cancer requires continual therapy, frequently done at home, prompting manufacturers to focus on user-friendly and more effective devices. Greater awareness and education on home healthcare services can further improve market penetration. Observed trends show that telemedicine and remote patient monitoring are rapidly gaining acceptance in China.

This development connects with home infusion therapy because healthcare practitioners can now monitor and modify therapy in real-time over the Internet. The government’s efforts to integrate digital health technologies into everyday healthcare are promoting an ecosystem where home infusion therapy devices can thrive. As the healthcare landscape in China evolves, these devices are becoming an integral part of patient care models, aligning with broader trends toward patient-centric healthcare solutions.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

## **China Home Infusion Therapy Devices Market Drivers**

### **Increasing Prevalence of Chronic Diseases**

China is experiencing a significant rise in chronic diseases such as diabetes, cardiovascular diseases, and cancer. According to the National Health Commission of China, there are over 300 million people living with diabetes in the country, which has increased from 12 million in 1980. The growing prevalence of these conditions necessitates home infusion therapy, as patients often require continuous medication through intravenous infusion for effective management.

This surge in chronic illness management is a key driver for the China Home Infusion Therapy Devices Market Industry, as healthcare providers are more inclined to adopt home-based treatment solutions that enhance patient compliance and provide cost-efficient care alternatives. Established organizations such as the Chinese Diabetes Society and the Cardiovascular Health Association of China emphasize the need for advanced home care devices, reinforcing the demand for innovative home infusion therapy solutions.

### **Technological Advancements in Home Infusion Devices**

The innovation in home infusion therapy devices has paved the way for better patient outcomes and usability. Recent advancements include automated infusion pumps and smart delivery systems that can monitor patient metrics in real-time. A report from the Ministry of Science and Technology of China highlighted that investments in healthcare technology innovation have increased by 50% over the last five years. Such technological advancements make home infusion therapy more patient-friendly and accessible, leading to a higher adoption rate.

The China Home Infusion Therapy Devices Market Industry is witnessing a favorable shift towards these advanced devices, making it a crucial market driver as healthcare stakeholders prioritize improving treatment efficacy.

### **Government Initiatives Supporting Home Healthcare**

The Chinese government has introduced several initiatives aimed at promoting home healthcare services, including home infusion therapy. The 14th Five-Year Plan for Health (2021-2025) lays out strategies for enhancing home healthcare capabilities to facilitate better patient care and healthcare access. This plan aims to increase the quality of medical services provided at home and advocates for the integration of modern technology in home care systems.

With government support, the China Home Infusion Therapy Devices Market Industry is set to benefit from increased funding and infrastructure development, essential for creating an ecosystem where home-based treatments can thrive.

## **China Home Infusion Therapy Devices Market Segment Insights**

### **Home Infusion Therapy Devices Market Device Type Insights**

The China Home Infusion Therapy Devices Market is witnessing significant advancements, particularly within the Device Type segment, which includes various essential tools such as infusion pumps, syringe pumps, ambulatory pumps, and enteral feeding pumps. Each of these device types plays a critical role in administering medication and nutrition to patients in home settings, driven by the rising prevalence of chronic illnesses and the increasing demand for home healthcare solutions. Infusion pumps are particularly pivotal as they provide precise control over the delivery of intravenous medication, ensuring that patients receive accurate dosages, which is vital for effective treatment outcomes.

Syringe pumps, on the other hand, are known for their compact design and efficiency in delivering small volumes of medications, making them suitable for pediatric care and home environments. Ambulatory pumps offer added flexibility, enabling patients to maintain mobility while receiving therapies, which is increasingly important as the aging population in China seeks to maintain independence despite health challenges. Enteral feeding pumps are essential for patients who require nutritional support but cannot consume food orally, thus improving quality of life and promoting better health outcomes.

The integration of technology within these devices is enhancing their functionality, providing features such as alarms for safety and mobile connectivity for remote monitoring, which aligns with the growing trend of telehealth in China.

As the home healthcare market expands, supported by government initiatives aimed at encouraging healthcare provisions outside traditional settings, the significance of these device types becomes more pronounced. While the China Home Infusion Therapy Devices Market is characterized by its diverse device offerings, the continued innovation and development in these types are indicative of the market's responsiveness to patient needs and the shift towards more patient-centered care. The growing emphasis on chronic disease management in the healthcare framework of China further reinforces the demand for these devices, ensuring they remain central to ongoing healthcare strategies and enhancing the overall patient experience.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

### **Home Infusion Therapy Devices Market Therapy Type Insights**

The Therapy Type segment within the China Home Infusion Therapy Devices Market is diverse, consisting of critical therapies such as Antibiotic Therapy, Chemotherapy, Nutrition Therapy, and Pain Management. Antibiotic Therapy plays a crucial role in managing infections, especially in home care settings, as it allows patients with chronic conditions to receive ongoing treatment without frequent hospital visits. Chemotherapy is significant for cancer patients, offering flexibility and comfort by enabling treatment at home, which is gaining traction as the population ages.

Nutrition Therapy is vital for patients requiring parenteral nutrition, supporting those with gastrointestinal disorders or other nutritional deficiencies, particularly in a country like China where lifestyle diseases are on the rise. Pain Management is increasingly significant as more patients prefer at-home solutions for chronic pain relief, highlighting a shift towards more personalized healthcare approaches. Collectively, these therapies contribute substantially to enhancing the quality of life for patients, showcasing the importance of the China Home Infusion Therapy Devices Market as healthcare systems evolve to meet the needs of an aging population and an increasing prevalence of chronic diseases.

### **Home Infusion Therapy Devices Market End User Insights**

The End User segment of the China Home Infusion Therapy Devices Market is witnessing notable growth, influenced by an increasing demand for efficient medical care and patient comfort within various settings. Hospitals are significant contributors, as they utilize these devices to enhance patient recovery processes, thereby reducing the length of hospital stays. Home Care Settings are also gaining traction, driven by the shift towards at-home healthcare solutions, supported by government initiatives aiming to lower healthcare costs and improve patient outcomes.

The aging population in China further propels the demand for nursing homes, where home infusion therapy provides essential therapies while ensuring patients receive care in a familiar environment. This segment's growth is attributed to rising chronic disease prevalence and the need for personalized healthcare services. Additionally, advancements in technology contribute to improved device efficacy and user-friendliness, aligning with the increasing expectations for home healthcare solutions among patients and healthcare professionals. Overall, the End User segment plays a crucial role in the landscape of the China Home Infusion Therapy Devices Market, catering to diverse healthcare needs and preferences.

### **Home Infusion Therapy Devices Market Components Insights**

The Components segment of the China Home Infusion Therapy Devices Market encompasses a diverse array of essential elements that facilitate effective patient care. Among these, Infusion Sets are pivotal as they directly connect patients to the infusion device, ensuring accurate delivery of medications. Catheters play a crucial role in maintaining patient comfort and accessibility for long-term therapies, showcasing their significance, especially in chronic conditions prevalent in China. Accessories, including sterilization tools and connectors, are vital for enhancing safety and efficiency, thus contributing to overall treatment success.

Additionally, Software Solutions have emerged as a crucial component, enhancing the management and monitoring of infusion therapies, which aligns with China’s growing emphasis on digital health innovations. The rising prevalence of chronic diseases in the country, combined with an increasing aging population, drives the demand for these components, making them significant contributors to the healthcare landscape. Together, these elements are increasingly recognized for their roles in improving patient outcomes, fostering market growth, and promoting seamless home care solutions within the China Home Infusion Therapy Devices Market.

## **China Home Infusion Therapy Devices Market Key Players and Competitive Insights**

The China Home Infusion Therapy Devices Market has emerged as a vital segment within the broader healthcare landscape, driven by an increasing prevalence of chronic diseases and a rising demand for the convenience of at-home care. Given the significant push towards patient-centered healthcare solutions, various players in this market are competing to introduce innovative products that enhance patient safety and comfort. The market consists of a diverse range of infusion devices, such as IV pumps, infusion sets, and accessories, and is characterized by intense competition among local and international manufacturers alike.

This competitive environment compels companies to focus on technological advancements, customer service, and regulatory compliance to establish a strong foothold in a rapidly evolving industry.

Changhua Juhua Medical Technology has carved a niche for itself in the China Home Infusion Therapy Devices Market, primarily due to its commitment to innovation and quality. The company has developed a robust portfolio of infusion devices that cater to various healthcare needs, ensuring that patients receive safe and effective therapy at home. Changhua Juhua Medical Technology leverages cutting-edge technology and adheres to stringent regulatory standards, enhancing its market presence. The company’s strengths lie in its well-established distribution channels and a strong reputation for customer support, enabling it to foster lasting relationships with healthcare providers and patients.

Furthermore, the emphasis on research and development positions the company favorably against its competitors, as it continually introduces advanced solutions tailored to market demands.

Guangdong Haisco Pharmaceutical maintains a significant presence in the China Home Infusion Therapy Devices Market through a comprehensive array of products and services. The company has established itself as a trusted provider of infusion systems, which include both general and specialized solutions aimed at different patient needs. Guangdong Haisco Pharmaceutical is well-regarded for its focus on quality and reliability, which has helped in building strong partnerships with healthcare institutions across China. The company has been active in mergers and acquisitions to strengthen its market position and expand its product offerings, further enhancing its competitive advantage.

With a keen emphasis on research-driven solutions and an agile approach to meeting market demands, Guangdong Haisco Pharmaceutical continues to capitalize on growth opportunities within the rapidly changing landscape of home infusion therapy.

### **Key Companies in the China Home Infusion Therapy Devices Market Include:**

## **China Home Infusion Therapy Devices Market Industry Developments**

The China Home Infusion Therapy Devices Market has recently witnessed notable developments. In August 2023, Changhua Juhua Medical Technology announced the expansion of its product line, introducing innovative infusion pumps tailored for pain management and chronic illness care. Meanwhile, Guangdong Haisco Pharmaceutical reported a strategic partnership deal in July 2023 to enhance its infusion device offerings, focusing on smart delivery systems that integrate with telemedicine.

In terms of mergers and acquisitions, Shenzhen Folee Medical Technology has been in the process of negotiating a merger with a smaller competitor, aiming to bolster its market share in home healthcare devices, although specific outcomes remain unconfirmed as of September 2023. Additionally, strong growth has been noted in the overall market valuation of companies like Baxter International and Fresenius Kabi, largely driven by increasing demand for home care solutions post-pandemic.

Over the last two years, advancements in technology and shifts toward decentralized care have fundamentally altered the landscape, with major players such as Medtronic and Terumo Corporation actively enhancing their product offerings to suit the growing need for at-home therapeutic solutions.

## **China Home Infusion Therapy Devices Market Segmentation Insights**

### **Home Infusion Therapy Devices Market Device Type Outlook**

### **Home Infusion Therapy Devices Market Therapy Type Outlook**

### **Home Infusion Therapy Devices Market End User Outlook**

### **Home Infusion Therapy Devices Market Components Outlook**

## Market Drivers

### Rising Awareness of Home Infusion Benefits

There is a growing awareness among healthcare professionals and patients regarding the benefits of home infusion therapies. The home infusion-therapy-devices market is likely to gain traction as more stakeholders recognize the advantages of at-home treatment, such as reduced hospital stays and lower healthcare costs. Educational initiatives and outreach programs are being implemented to inform patients about the efficacy and safety of home infusion therapies. This increased awareness is expected to drive demand for home infusion devices, as patients seek to manage their conditions more effectively from home. As a result, the market is poised for growth, with an increasing number of patients opting for home-based infusion solutions.

### Technological Innovations in Infusion Devices

The home infusion-therapy-devices market is being propelled by rapid technological innovations that enhance the functionality and usability of infusion devices. Recent advancements include the development of smart infusion pumps equipped with connectivity features that allow for remote monitoring and data sharing. These innovations not only improve patient safety but also facilitate better management of infusion therapies. In China, the infusion pump market is projected to reach $1.5 billion by 2026, indicating a robust growth trajectory. As healthcare providers increasingly adopt these advanced technologies, the home infusion-therapy-devices market is likely to expand, offering patients more effective and user-friendly treatment options.

### Aging Population and Increased Healthcare Needs

China's demographic landscape is undergoing a significant transformation, with a rapidly aging population that is expected to reach 400 million by 2040. This demographic shift is likely to create a substantial increase in healthcare needs, particularly for chronic disease management. The home infusion-therapy-devices market stands to benefit from this trend, as older adults often require ongoing medical treatments that can be effectively managed at home. The demand for infusion therapies is anticipated to rise, as these devices provide a convenient and efficient means of delivering medications. Furthermore, the government is likely to support initiatives aimed at improving home healthcare services, which could further enhance the market's growth prospects.

### Increasing Demand for Home Healthcare Solutions

The home infusion-therapy-devices market is experiencing a notable surge in demand for home healthcare solutions in China. This trend is largely driven by the growing preference for at-home treatment options among patients, particularly those with chronic conditions. As healthcare costs continue to rise, patients are increasingly seeking alternatives that allow them to receive care in the comfort of their homes. According to recent data, the home healthcare market in China is projected to grow at a CAGR of approximately 15% over the next five years. This shift towards home-based care is likely to bolster the home infusion-therapy-devices market, as more patients require infusion therapies that can be administered outside of traditional clinical settings.

### Government Initiatives to Promote Home Healthcare

The Chinese government is actively promoting home healthcare services as part of its broader healthcare reform agenda. This initiative aims to alleviate the burden on hospitals and improve access to care for patients, particularly in rural areas. The home infusion therapy devices market is likely to benefit from these government efforts, as policies are being developed to support the integration of home-based therapies into the healthcare system. Financial incentives and subsidies for home healthcare providers may further stimulate market growth. As the government continues to invest in healthcare infrastructure and services, the home infusion-therapy-devices market is expected to expand, providing patients with more options for receiving care at home.

## Future Outlook

The [Home Infusion Therapy Devices Market](https://www.marketresearchfuture.com/reports/home-infusion-therapy-devices-market-7906) in China is projected to grow at a 5.09% CAGR from 2025 to 2035, driven by technological advancements and increasing patient demand.

**New opportunities:**

- Development of portable infusion pumps for home use
- Integration of telehealth services with infusion therapy
- Expansion of training programs for healthcare professionals in home settings

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare dynamics.

## Segment Insights

### By Device Type: Infusion Pumps (Largest) vs. IV Sets (Fastest-Growing)

The market share distribution in the China home infusion-therapy-devices market reveals that Infusion Pumps hold a significant portion, establishing themselves as the dominant device type. Following them are IV Sets, which are increasingly gaining traction among healthcare providers due to their essential role in patient care. Other key segments, such as Needles and Cannulas, Syringe Pumps, and Infusion Accessories, also contribute to a diverse market, but their shares remain relatively smaller compared to the top two segments.

Growth trends indicate a robust demand for Infusion Pumps driven by advancements in technology and improved patient outcomes. Meanwhile, IV Sets are identified as the fastest-growing segment, attributed to their critical role in various medical procedures, particularly in outpatient care settings. The ongoing shift towards home healthcare solutions is spurring investments in these devices, forecasting a promising future for the overall segment.

Infusion Pumps (Dominant) vs. IV Sets (Emerging)

Infusion Pumps are a dominant force in the market, recognized for their precision and reliability in delivering medications and fluids to patients. They are essential in critical care environments, showcasing advanced features such as programmable settings and safety alarms that enhance patient safety. In contrast, IV Sets are considered an emerging segment, rapidly gaining popularity due to innovations that improve usability and reduce the risk of complications. As healthcare providers seek to enhance efficiency and patient safety, IV Sets are increasingly being favored, particularly in home healthcare scenarios. Together, these segments reflect the dynamic nature of the market, highlighting both established and emerging players in the infusion therapy landscape.

### By Application: Antibiotics (Largest) vs. Chemotherapy (Fastest-Growing)

In the China home infusion-therapy-devices market, the application segment reveals a diverse share among its values. Antibiotics stand out as the largest application, greatly influencing the overall market. Chemotherapy, while not the largest, has been gaining traction quickly, showcasing robust demand and a growing customer base as more patients seek advanced treatment options. Other applications, such as Enteral Nutrition, Pain Management, and Hydration Therapy, contribute to the market but with comparatively smaller market shares.

Growth trends within the application segment are largely driven by the increasing prevalence of chronic diseases and the rising demand for home-based healthcare solutions. The shift towards outpatient services and the development of more sophisticated infusion therapies are propelling the chemotherapy segment forward. As healthcare providers continue to adopt these technologies, the landscape of home infusion therapies in China is expected to evolve, further enhancing patient outcomes and accessibility.

Antibiotics (Dominant) vs. Chemotherapy (Emerging)

Antibiotics have established themselves as the dominant application in home infusion therapies, largely due to their essential role in treating bacterial infections and supporting patient recovery. The availability of various antibiotic formulations and advancements in device technologies have made it easier for patients to receive these treatments at home, thus reducing hospital stays. On the other hand, chemotherapy is characterized as an emerging segment, reflecting its rapid growth driven by the rising incidence of cancer and the shift towards more personalized treatment protocols. As both segments evolve, innovations in delivery methods and patient monitoring will play critical roles in enhancing the efficacy and safety of antibiotic and chemotherapy treatments in home settings.

### By End User: Hospitals (Largest) vs. Homecare Settings (Fastest-Growing)

In the China home infusion-therapy-devices market, hospitals command the largest share, driven by their comprehensive healthcare services and the need for advanced infusion therapies. Homecare settings are emerging rapidly, appealing to patients seeking comfort and convenience, particularly for long-term treatment and chronic conditions. This distribution reflects the growing trend towards personalized healthcare solutions.

Currently, the growth trends indicate a significant shift toward homecare settings, influenced by technological advancements and increasing patient preference for receiving care at home. Ambulatory surgical centers and nursing homes also contribute, but their growth is not as pronounced. The increasing prevalence of chronic illnesses and an aging population further drive demand for efficient and convenient infusion solutions in these settings.

Hospitals (Dominant) vs. Homecare Settings (Emerging)

Hospitals represent the dominant segment in the home infusion-therapy-devices market, equipped with advanced medical technology and skilled healthcare professionals that ensure effective and safe infusion therapy management. Their infrastructure supports a wide range of infusion therapies essential for acute and chronic conditions, providing a strong foundation for patient care. In contrast, homecare settings are emerging rapidly, driven by technological innovations that facilitate remote monitoring and patient management. Convenience, cost-effectiveness, and patients' preferences for home treatment are pivotal factors boosting the growth of this segment. As healthcare systems evolve, the integration of infusion therapies within homecare represents a significant shift, catering to a demographic that increasingly values home-based healthcare solutions.

### By Product: Smart Infusion Pumps (Largest) vs. Portable Infusion Devices (Fastest-Growing)

In the China home infusion-therapy-devices market, Smart Infusion Pumps dominate the product segment, holding the largest market share due to their advanced features and widespread acceptance among healthcare providers. Portable Infusion Devices, while smaller in market share, are witnessing rapid growth driven by increasing demand for home care solutions and patient convenience. The market for both devices reflects a keen interest in enhancing patient outcomes and improving treatment efficiency.

Growth trends in this segment indicate a robust trajectory for Smart Infusion Pumps, attributed to technological advancements and a shift towards personalized medicine. The Portable Infusion Devices segment is emerging quickly, fueled by demographic shifts such as an aging population and a rise in chronic diseases. These trends emphasize the importance of accessibility and flexibility in treatment delivery, positioning these devices as indispensable in modern healthcare settings.

Technology: Smart Infusion Pumps (Dominant) vs. Portable Infusion Devices (Emerging)

Smart Infusion Pumps are characterized by their sophisticated technology, which includes features such as dose-error reduction systems and wireless connectivity, making them the preferred choice in hospitals and home care settings. Their ability to ensure precise medication delivery enhances safety and efficacy, leading to widespread adoption. In contrast, Portable Infusion Devices focus on flexibility and convenience, designed for patients who require therapy at home or on-the-go. As these devices become increasingly user-friendly and efficient, their emerging market position highlights a transformative shift towards more patient-centric care in the China home infusion-therapy-devices market.

## Competitive Benchmarking

The home infusion-therapy-devices market in China is characterized by a dynamic competitive landscape, driven by increasing demand for at-home healthcare solutions and advancements in technology. Major players such as Baxter International Inc (US), B. Braun Melsungen AG (DE), and Fresenius Kabi AG (DE) are strategically positioned to leverage these trends. Baxter International Inc (US) focuses on innovation in infusion systems, emphasizing the development of smart devices that enhance patient safety and treatment efficacy. Meanwhile, B. Braun Melsungen AG (DE) is enhancing its operational focus on regional expansion, particularly in underserved markets, to capture a larger share of the growing demand. Fresenius Kabi AG (DE) appears to be concentrating on partnerships with local healthcare providers to improve service delivery and patient outcomes, thereby shaping a competitive environment that prioritizes quality and accessibility.
Key business tactics within this market include localizing manufacturing and optimizing supply chains to reduce costs and improve responsiveness to market needs. The competitive structure is moderately fragmented, with several key players influencing market dynamics through their diverse product offerings and strategic initiatives. This fragmentation allows for a variety of solutions tailored to specific patient needs, fostering innovation and competition among manufacturers.
In October 2025, Baxter International Inc (US) announced the launch of a new line of infusion pumps designed specifically for home use, featuring advanced connectivity options that allow for real-time monitoring by healthcare professionals. This strategic move is likely to enhance patient safety and adherence to treatment protocols, positioning Baxter as a leader in the home infusion segment. The introduction of these devices may also reflect a broader trend towards integrating digital health solutions into traditional medical devices.
In September 2025, B. Braun Melsungen AG (DE) expanded its manufacturing capabilities in China by establishing a new facility dedicated to producing infusion therapy products. This expansion is significant as it not only increases production capacity but also aligns with the company’s strategy to localize its supply chain, thereby reducing lead times and costs. Such initiatives may enhance B. Braun's competitive edge in a rapidly evolving market.
In August 2025, Fresenius Kabi AG (DE) entered into a strategic partnership with a leading telehealth provider to integrate remote patient monitoring with its infusion therapy devices. This collaboration is indicative of a growing trend towards digitalization in healthcare, allowing for better patient management and potentially improved outcomes. By embracing telehealth solutions, Fresenius Kabi is likely to enhance its service offerings and strengthen its market position.
As of November 2025, current competitive trends in the home infusion-therapy-devices market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to innovate more effectively. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on innovation, technology integration, and supply chain reliability, reflecting the changing needs of healthcare providers and patients alike.

## Recent News & Developments

The China Home Infusion Therapy Devices Market has recently witnessed notable developments. In August 2023, Changhua Juhua Medical Technology announced the expansion of its product line, introducing innovative infusion pumps tailored for pain management and chronic illness care. Meanwhile, Guangdong Haisco Pharmaceutical reported a strategic partnership deal in July 2023 to enhance its infusion device offerings, focusing on smart delivery systems that integrate with telemedicine.

In terms of mergers and acquisitions, Shenzhen Folee Medical Technology has been in the process of negotiating a merger with a smaller competitor, aiming to bolster its market share in home healthcare devices, although specific outcomes remain unconfirmed as of September 2023. Additionally, strong growth has been noted in the overall market valuation of companies like Baxter International and Fresenius Kabi, largely driven by increasing demand for home care solutions post-pandemic.

Over the last two years, advancements in technology and shifts toward decentralized care have fundamentally altered the landscape, with major players such as Medtronic and Terumo Corporation actively enhancing their product offerings to suit the growing need for at-home therapeutic solutions.

## Report Scope

| MARKET SIZE 2024 | 512.25(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 538.32(USD Million) |
| MARKET SIZE 2035 | 884.4(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.09% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Baxter International Inc (US), B. Braun Melsungen AG (DE), Fresenius Kabi AG (DE), Medtronic plc (IE), Smiths Medical (US), ICU Medical Inc (US), Terumo Corporation (JP), Halyard Health Inc (US), Zyno Medical LLC (US) |
| Segments Covered | Device Type, Application, End User, Product |
| Key Market Opportunities | Integration of advanced telehealth solutions enhances patient monitoring in the home infusion-therapy-devices market. |
| Key Market Dynamics | Rising demand for home infusion-therapy-devices driven by regulatory support and technological advancements in China. |
| Countries Covered | China |

## Frequently Asked Questions

**Q: What is the current valuation of the home infusion-therapy-devices market in China?**
A: The market valuation was $512.25 Million in 2024.

**Q: What is the projected market size for the home infusion-therapy-devices market in China by 2035?**
A: The projected valuation for 2035 is $884.4 Million.

**Q: What is the expected CAGR for the home infusion-therapy-devices market in China during the forecast period 2025 - 2035?**
A: The expected CAGR is 5.09% during the forecast period.

**Q: Which device type segment had the highest valuation in 2024?**
A: The IV Sets segment had the highest valuation at $220.0 Million in 2024.

**Q: What is the projected valuation for the Smart Infusion Pumps segment by 2035?**
A: The Smart Infusion Pumps segment is projected to reach $350.0 Million by 2035.

**Q: Which application segment is expected to grow the most in the home infusion-therapy-devices market?**
A: The Hydration Therapy segment is projected to grow significantly, reaching $234.4 Million by 2035.

**Q: What was the valuation of the homecare settings end user segment in 2024?**
A: The homecare settings segment was valued at $200.0 Million in 2024.

**Q: Which key player is recognized for its leadership in the home infusion-therapy-devices market?**
A: Baxter International Inc is recognized as a key player in the market.

**Q: What is the projected growth for the Portable Infusion Devices segment by 2035?**
A: The Portable Infusion Devices segment is projected to grow to $180.0 Million by 2035.

**Q: How does the valuation of the Nursing Homes end user segment compare to others in 2024?**
A: The Nursing Homes segment was valued at $62.25 Million, the lowest among the end user segments in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/china-home-infusion-therapy-devices-market-50764*